| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | G protein-coupled opioid receptor activity | 6.48e-08 | 7 | 133 | 4 | GO:0004985 | |
| GeneOntologyMolecularFunction | neuropeptide binding | 4.47e-06 | 37 | 133 | 5 | GO:0042923 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | NPC1 OR5T1 NPBWR1 GPR12 GPR21 PECAM1 GPR52 GPRC6A OR2T34 OPRD1 OPRK1 OPRL1 TLR10 OR2A12 NRXN3 NRXN2 P2RY2 P2RY4 OR51B6 GPR149 GPR75 OR10G8 PLXNA1 | 2.87e-05 | 1353 | 133 | 23 | GO:0004888 |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | LARS1 SRGAP2 SIPA1 DOCK5 ARFGEF3 HPS4 THG1L NGEF SESN2 SIPA1L2 IQGAP3 USP6NL NCKAP1L | 3.49e-05 | 507 | 133 | 13 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | LARS1 SRGAP2 SIPA1 DOCK5 ARFGEF3 HPS4 THG1L NGEF SESN2 SIPA1L2 IQGAP3 USP6NL NCKAP1L | 3.49e-05 | 507 | 133 | 13 | GO:0030695 |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR5T1 NPBWR1 GPR12 GPR21 GPR52 GPRC6A OR2T34 OPRD1 OPRK1 OPRL1 OR2A12 P2RY2 P2RY4 OR51B6 GPR149 GPR75 OR10G8 | 8.18e-05 | 884 | 133 | 17 | GO:0004930 |
| GeneOntologyMolecularFunction | G protein-coupled UTP receptor activity | 1.32e-04 | 3 | 133 | 2 | GO:0045030 | |
| GeneOntologyMolecularFunction | G protein-coupled pyrimidinergic nucleotide receptor activity | 2.62e-04 | 4 | 133 | 2 | GO:0071553 | |
| GeneOntologyMolecularFunction | neuroligin family protein binding | 4.35e-04 | 5 | 133 | 2 | GO:0097109 | |
| GeneOntologyMolecularFunction | GTPase activator activity | 5.71e-04 | 279 | 133 | 8 | GO:0005096 | |
| GeneOntologyMolecularFunction | GTPase binding | 6.98e-04 | 360 | 133 | 9 | GO:0051020 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 8.38e-04 | 28 | 133 | 3 | GO:0051959 | |
| GeneOntologyMolecularFunction | L-leucine binding | 9.05e-04 | 7 | 133 | 2 | GO:0070728 | |
| GeneOntologyMolecularFunction | small GTPase binding | 1.41e-03 | 321 | 133 | 8 | GO:0031267 | |
| GeneOntologyBiologicalProcess | G protein-coupled opioid receptor signaling pathway | 1.16e-06 | 13 | 134 | 4 | GO:0038003 | |
| GeneOntologyBiologicalProcess | neuron cell-cell adhesion | 2.92e-06 | 16 | 134 | 4 | GO:0007158 | |
| GeneOntologyBiologicalProcess | negative regulation of dendritic spine development | 4.86e-06 | 18 | 134 | 4 | GO:0061000 | |
| GeneOntologyBiologicalProcess | extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration | 4.19e-05 | 2 | 134 | 2 | GO:0021816 | |
| GeneOntologyBiologicalProcess | dense core granule docking | 4.19e-05 | 2 | 134 | 2 | GO:0061790 | |
| GeneOntologyBiologicalProcess | cellular response to L-leucine | 7.31e-05 | 13 | 134 | 3 | GO:0071233 | |
| GeneOntologyCellularComponent | synaptic membrane | UNC13B SRGAP2 OPRD1 OPRK1 OPRL1 SLC12A5 NLGN3 NRXN3 PLPPR4 NRXN2 P2RY2 P2RY4 KCND2 UNC13A | 2.54e-05 | 583 | 135 | 14 | GO:0097060 |
| GeneOntologyCellularComponent | glutamatergic synapse | UNC13B SRGAP2 NLGN3 SRGAP2C NRXN3 PLPPR4 NRXN2 P2RY2 P2RY4 KCND2 NGEF SRGAP2B SIPA1L2 TNR UNC13A PLXNA1 | 7.69e-05 | 817 | 135 | 16 | GO:0098978 |
| GeneOntologyCellularComponent | presynaptic active zone | 3.12e-04 | 141 | 135 | 6 | GO:0048786 | |
| GeneOntologyCellularComponent | presynaptic membrane | 4.46e-04 | 277 | 135 | 8 | GO:0042734 | |
| Domain | srGAP2 | 3.37e-07 | 3 | 131 | 3 | IPR030252 | |
| Domain | Opioid_rcpt | 1.34e-06 | 4 | 131 | 3 | IPR001418 | |
| Domain | Sterol-sensing | 3.34e-06 | 5 | 131 | 3 | PF12349 | |
| Domain | GPCR_Rhodpsn_7TM | OR5T1 NPBWR1 GPR12 GPR21 GPR52 OR2T34 OPRD1 OPRK1 OPRL1 OR2A12 P2RY2 P2RY4 OR51B6 GPR149 GPR75 OR10G8 | 1.88e-05 | 670 | 131 | 16 | IPR017452 |
| Domain | 7tm_1 | OR5T1 NPBWR1 GPR12 GPR21 GPR52 OR2T34 OPRD1 OPRK1 OPRL1 OR2A12 P2RY2 P2RY4 OR51B6 GPR149 GPR75 OR10G8 | 2.14e-05 | 677 | 131 | 16 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | OR5T1 NPBWR1 GPR12 GPR21 GPR52 OR2T34 OPRD1 OPRK1 OPRL1 OR2A12 P2RY2 P2RY4 OR51B6 GPR149 GPR75 OR10G8 | 2.47e-05 | 685 | 131 | 16 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | OR5T1 NPBWR1 GPR12 GPR21 GPR52 OR2T34 OPRD1 OPRK1 OPRL1 OR2A12 P2RY2 P2RY4 OR51B6 GPR149 GPR75 OR10G8 | 2.74e-05 | 691 | 131 | 16 | PS50262 |
| Domain | GPCR_Rhodpsn | OR5T1 NPBWR1 GPR12 GPR21 GPR52 OR2T34 OPRD1 OPRK1 OPRL1 OR2A12 P2RY2 P2RY4 OR51B6 GPR149 GPR75 OR10G8 | 2.79e-05 | 692 | 131 | 16 | IPR000276 |
| Domain | NPC1_N | 4.88e-05 | 2 | 131 | 2 | IPR032190 | |
| Domain | NP_C_type | 4.88e-05 | 2 | 131 | 2 | IPR004765 | |
| Domain | NPC1_N | 4.88e-05 | 2 | 131 | 2 | PF16414 | |
| Domain | SSD | 9.16e-05 | 13 | 131 | 3 | IPR000731 | |
| Domain | SSD | 9.16e-05 | 13 | 131 | 3 | PS50156 | |
| Domain | Unc-13 | 1.46e-04 | 3 | 131 | 2 | IPR027080 | |
| Domain | - | 2.55e-04 | 18 | 131 | 3 | 1.20.144.10 | |
| Domain | acidPPc | 2.55e-04 | 18 | 131 | 3 | SM00014 | |
| Domain | P_Acid_Pase_2/haloperoxidase | 3.52e-04 | 20 | 131 | 3 | IPR000326 | |
| Domain | PAP2 | 3.52e-04 | 20 | 131 | 3 | PF01569 | |
| Domain | FCH | 4.71e-04 | 22 | 131 | 3 | PF00611 | |
| Domain | FCH | 4.71e-04 | 22 | 131 | 3 | SM00055 | |
| Domain | Munc13_dom-2 | 4.82e-04 | 5 | 131 | 2 | IPR014772 | |
| Domain | MHD2 | 4.82e-04 | 5 | 131 | 2 | PS51259 | |
| Domain | Munc13_subgr_dom-2 | 4.82e-04 | 5 | 131 | 2 | IPR019558 | |
| Domain | Membr_traf_MHD | 4.82e-04 | 5 | 131 | 2 | PF10540 | |
| Domain | DUF1041 | 4.82e-04 | 5 | 131 | 2 | SM01145 | |
| Domain | FCH_dom | 5.39e-04 | 23 | 131 | 3 | IPR001060 | |
| Domain | F_BAR | 6.93e-04 | 25 | 131 | 3 | IPR031160 | |
| Domain | F_BAR | 6.93e-04 | 25 | 131 | 3 | PS51741 | |
| Domain | Munc13_1 | 1.00e-03 | 7 | 131 | 2 | IPR014770 | |
| Domain | MHD1 | 1.00e-03 | 7 | 131 | 2 | PS51258 | |
| Domain | Syndecan | 1.00e-03 | 7 | 131 | 2 | PF01034 | |
| Domain | ZnF_UBR1 | 1.00e-03 | 7 | 131 | 2 | SM00396 | |
| Domain | DUF1041 | 1.00e-03 | 7 | 131 | 2 | PF06292 | |
| Domain | CAPS_dom | 1.00e-03 | 7 | 131 | 2 | IPR010439 | |
| Domain | ZF_UBR | 1.00e-03 | 7 | 131 | 2 | PS51157 | |
| Domain | zf-UBR | 1.00e-03 | 7 | 131 | 2 | PF02207 | |
| Domain | Znf_UBR | 1.00e-03 | 7 | 131 | 2 | IPR003126 | |
| Domain | Syndecan/Neurexin_dom | 1.00e-03 | 7 | 131 | 2 | IPR027789 | |
| Domain | 7TM_GPCR_Srsx | 1.16e-03 | 112 | 131 | 5 | SM01381 | |
| Domain | Ptc/Disp | 1.70e-03 | 9 | 131 | 2 | IPR003392 | |
| Domain | Patched | 1.70e-03 | 9 | 131 | 2 | PF02460 | |
| Domain | Rap_GAP | 2.12e-03 | 10 | 131 | 2 | PF02145 | |
| Domain | Rap_GAP_dom | 2.58e-03 | 11 | 131 | 2 | IPR000331 | |
| Domain | RAPGAP | 2.58e-03 | 11 | 131 | 2 | PS50085 | |
| Domain | Neurexin-like | 4.20e-03 | 14 | 131 | 2 | IPR003585 | |
| Domain | 4.1m | 4.20e-03 | 14 | 131 | 2 | SM00294 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | NPBWR1 GPR12 GPR21 GPR52 OPRD1 OPRK1 OPRL1 P2RY2 P2RY4 GPR75 | 2.18e-05 | 260 | 104 | 10 | M39397 |
| Pubmed | 5.98e-08 | 3 | 137 | 3 | 22559944 | ||
| Pubmed | Identification of a novel family of G protein-coupled receptor associated sorting proteins. | 2.24e-07 | 14 | 137 | 4 | 15086532 | |
| Pubmed | Evolution of human-specific neural SRGAP2 genes by incomplete segmental duplication. | 2.38e-07 | 4 | 137 | 3 | 22559943 | |
| Pubmed | 2.38e-07 | 4 | 137 | 3 | 11430857 | ||
| Pubmed | Multiple opioid receptor-like genes are identified in diverse vertebrate phyla. | 2.38e-07 | 4 | 137 | 3 | 8941707 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | NPC1 UNC13B TEAD2 SLC35B3 UBR4 TMC6 HECTD4 ST3GAL1 SRGAP2 LRRK1 ATP13A2 GBA2 SCAP ZBED4 PIGW SIPA1L2 IQGAP3 PLXNA1 | 3.78e-07 | 1105 | 137 | 18 | 35748872 |
| Pubmed | 5.95e-07 | 5 | 137 | 3 | 27645114 | ||
| Pubmed | Structures, alternative splicing, and neurexin binding of multiple neuroligins. | 1.19e-06 | 6 | 137 | 3 | 8576240 | |
| Pubmed | Expression of astrocyte-related receptors in cortical dysplasia with intractable epilepsy. | 2.07e-06 | 7 | 137 | 3 | 25003238 | |
| Pubmed | Neuroligin-1 Signaling Controls LTP and NMDA Receptors by Distinct Molecular Pathways. | 3.30e-06 | 8 | 137 | 3 | 30871858 | |
| Pubmed | 4.94e-06 | 9 | 137 | 3 | 34919427 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | CDS1 MYT1 TMC6 HECTD4 PAQR5 ST3GAL1 SRGAP2 IDE PTPN18 NEK9 OPRL1 DOCK5 ARFGEF3 NLGN3 PPP2R3A NGEF TMEM143 CATSPERG CNOT1 | 6.41e-06 | 1489 | 137 | 19 | 28611215 |
| Pubmed | GPRASP1 HECW1 UBR4 HECTD4 SRGAP2 SIPA1 NEK9 SLC12A5 NLGN3 PLPPR4 NGEF TNR TNS1 CNOT1 UNC13A | 6.50e-06 | 963 | 137 | 15 | 28671696 | |
| Pubmed | 9.64e-06 | 11 | 137 | 3 | 32973045 | ||
| Pubmed | Distribution of P2Y receptor subtypes on haematopoietic cells. | 1.54e-05 | 2 | 137 | 2 | 9535005 | |
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 7802669 | ||
| Pubmed | K+ secretion activated by luminal P2Y2 and P2Y4 receptors in mouse colon. | 1.54e-05 | 2 | 137 | 2 | 15718265 | |
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 32407927 | ||
| Pubmed | TGFβ1 mediates alcohol-induced Nrf2 suppression in lung fibroblasts. | 1.54e-05 | 2 | 137 | 2 | 25421510 | |
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 19836435 | ||
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 12871971 | ||
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 17561838 | ||
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 37336368 | ||
| Pubmed | Cloning and functional comparison of kappa and delta opioid receptors from mouse brain. | 1.54e-05 | 2 | 137 | 2 | 8393575 | |
| Pubmed | Heterodimerization of Munc13 C2A domain with RIM regulates synaptic vesicle docking and priming. | 1.54e-05 | 2 | 137 | 2 | 28489077 | |
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 24278116 | ||
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 27373832 | ||
| Pubmed | Munc13-1 is essential for fusion competence of glutamatergic synaptic vesicles. | 1.54e-05 | 2 | 137 | 2 | 10440375 | |
| Pubmed | Inhibition of exocytosis or endocytosis blocks activity-dependent redistribution of synapsin. | 1.54e-05 | 2 | 137 | 2 | 22066784 | |
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 26226105 | ||
| Pubmed | Ultrastructural Correlates of Presynaptic Functional Heterogeneity in Hippocampal Synapses. | 1.54e-05 | 2 | 137 | 2 | 32187536 | |
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 11316510 | ||
| Pubmed | Reducing GBA2 Activity Ameliorates Neuropathology in Niemann-Pick Type C Mice. | 1.54e-05 | 2 | 137 | 2 | 26275242 | |
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 19607885 | ||
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 22814762 | ||
| Pubmed | Formation and Maintenance of Functional Spines in the Absence of Presynaptic Glutamate Release. | 1.54e-05 | 2 | 137 | 2 | 28426965 | |
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 17622222 | ||
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 23770256 | ||
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 19900397 | ||
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 26915435 | ||
| Pubmed | Murine model of Niemann-Pick C disease: mutation in a cholesterol homeostasis gene. | 1.54e-05 | 2 | 137 | 2 | 9211850 | |
| Pubmed | The histone demethylase PHF8 regulates TGFβ signaling and promotes melanoma metastasis. | 1.54e-05 | 2 | 137 | 2 | 35179962 | |
| Pubmed | Calcium-Independent Exo-endocytosis Coupling at Small Central Synapses. | 1.54e-05 | 2 | 137 | 2 | 31851910 | |
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 17662536 | ||
| Pubmed | Differential control of vesicle priming and short-term plasticity by Munc13 isoforms. | 1.54e-05 | 2 | 137 | 2 | 11832228 | |
| Pubmed | Munc13 controls the location and efficiency of dense-core vesicle release in neurons. | 1.54e-05 | 2 | 137 | 2 | 23229896 | |
| Pubmed | Nrf2-ARE pathway regulates induction of Sestrin-2 expression. | 1.54e-05 | 2 | 137 | 2 | 22749810 | |
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 16331961 | ||
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 30375371 | ||
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 12070347 | ||
| Pubmed | The adhesion molecule PECAM-1 enhances the TGF-β-mediated inhibition of T cell function. | 1.54e-05 | 2 | 137 | 2 | 26956486 | |
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 21507342 | ||
| Pubmed | Identification of kappa- and delta-opioid receptor transcripts in immune cells. | 1.54e-05 | 2 | 137 | 2 | 7649271 | |
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 23070049 | ||
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 19674192 | ||
| Pubmed | Anti-nociception mediated by a κ opioid receptor agonist is blocked by a δ receptor agonist. | 1.54e-05 | 2 | 137 | 2 | 24923251 | |
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 31822692 | ||
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 32144204 | ||
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 10880563 | ||
| Pubmed | Molecular Mechanisms of Synaptic Vesicle Priming by Munc13 and Munc18. | 1.54e-05 | 2 | 137 | 2 | 28772123 | |
| Pubmed | G-protein-coupled receptor heterodimerization modulates receptor function. | 1.54e-05 | 2 | 137 | 2 | 10385123 | |
| Pubmed | Munc13-1 C1 domain activation lowers the energy barrier for synaptic vesicle fusion. | 1.54e-05 | 2 | 137 | 2 | 17267576 | |
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 9155012 | ||
| Pubmed | Inter-domain dynamics drive cholesterol transport by NPC1 and NPC1L1 proteins. | 1.54e-05 | 2 | 137 | 2 | 32410728 | |
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 35613050 | ||
| Pubmed | Membrane bridging by Munc13-1 is crucial for neurotransmitter release. | 1.54e-05 | 2 | 137 | 2 | 30816091 | |
| Pubmed | A common molecular basis for membrane docking and functional priming of synaptic vesicles. | 1.54e-05 | 2 | 137 | 2 | 19558619 | |
| Pubmed | Discovery and validation of 3 novel DNA methylation markers of prostate cancer prognosis. | 1.54e-05 | 2 | 137 | 2 | 17437806 | |
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 18701688 | ||
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 25439010 | ||
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 16712978 | ||
| Pubmed | Generation and function of astroglial lipoproteins from Niemann-Pick type C1-deficient mice. | 1.54e-05 | 2 | 137 | 2 | 15544574 | |
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 11792326 | ||
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 39113713 | ||
| Pubmed | 2.76e-05 | 493 | 137 | 10 | 15368895 | ||
| Pubmed | Loss of PiT-1 results in abnormal endocytosis in the yolk sac visceral endoderm. | 3.90e-05 | 17 | 137 | 3 | 25138534 | |
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 38891114 | ||
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 20106877 | ||
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 11109025 | ||
| Pubmed | Bardoxolone ameliorates TGF-β1-associated renal fibrosis through Nrf2/Smad7 elevation. | 4.61e-05 | 3 | 137 | 2 | 31059771 | |
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 10082819 | ||
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 38331008 | ||
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 26169693 | ||
| Pubmed | Effects of opioid receptor gene variation on targeted nalmefene treatment in heavy drinkers. | 4.61e-05 | 3 | 137 | 2 | 18537939 | |
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 12603260 | ||
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 16406382 | ||
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 16192643 | ||
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 15178356 | ||
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 31005376 | ||
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 11259526 | ||
| Pubmed | Pharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors. | 4.61e-05 | 3 | 137 | 2 | 8114680 | |
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 11032994 | ||
| Pubmed | Loss of nucleotide regulation of epithelial chloride transport in the jejunum of P2Y4-null mice. | 4.61e-05 | 3 | 137 | 2 | 12644577 | |
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 25855262 | ||
| Pubmed | Opioid receptors: from binding sites to visible molecules in vivo. | 4.61e-05 | 3 | 137 | 2 | 18718480 | |
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 26904167 | ||
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 33105896 | ||
| Pubmed | Regulated Dynamic Trafficking of Neurexins Inside and Outside of Synaptic Terminals. | 4.61e-05 | 3 | 137 | 2 | 26446217 | |
| Pubmed | Analysis of the human neurexin genes: alternative splicing and the generation of protein diversity. | 4.61e-05 | 3 | 137 | 2 | 11944992 | |
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 18213616 | ||
| GeneFamily | Opioid receptors | 5.96e-07 | 4 | 97 | 3 | 245 | |
| GeneFamily | G protein-coupled receptors, Class A orphans | 6.21e-05 | 78 | 97 | 5 | 262 | |
| GeneFamily | UNC13 homologs | 1.70e-04 | 4 | 97 | 2 | 836 | |
| GeneFamily | Rho GTPase activating proteins|F-BAR domain containing | 2.45e-04 | 23 | 97 | 3 | 1288 | |
| GeneFamily | Phospholipid phosphatase related | 2.82e-04 | 5 | 97 | 2 | 1127 | |
| GeneFamily | Ubiquitin protein ligase E3 component n-recognins | 5.88e-04 | 7 | 97 | 2 | 785 | |
| GeneFamily | Purinergic receptors P2Y | 1.25e-03 | 10 | 97 | 2 | 213 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29977_top-relative-expression-ranked_500 | KLHL6 PLK2 PECAM1 TMC6 CPA3 SRGAP2 SIPA1 PTPN18 TGFB1 EPAS1 PLD4 NCKAP1L | 3.72e-06 | 384 | 128 | 12 | DevelopingKidney_e15.5_Endothelial cells_emap-29977_500 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k-means-cluster#5_top-relative-expression-ranked_1000 | KLHL6 PLK2 GPR12 CPA3 SRGAP2 SIPA1 TGFB1 NFE2L2 RMC1 EPAS1 PLD4 NCKAP1L | 1.17e-05 | 430 | 128 | 12 | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k5_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29977_top-relative-expression-ranked_1000 | KLHL6 PLK2 GPR12 PECAM1 TMC6 CPA3 SRGAP2 SIPA1 PTPN18 SLC12A5 TGFB1 NFE2L2 RMC1 EPAS1 PLD4 NCKAP1L | 1.47e-05 | 764 | 128 | 16 | DevelopingKidney_e15.5_Endothelial cells_emap-29977_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k-means-cluster#5_top-relative-expression-ranked_500 | 2.27e-05 | 193 | 128 | 8 | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k5_500 | |
| ToppCell | Fetal_29-31_weeks-Immune-dendritic_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.30e-06 | 177 | 137 | 7 | c5e829bc4594761666d65cace5a9c5d19c16f187 | |
| ToppCell | Globus_pallidus-Neuronal|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.08e-06 | 190 | 137 | 7 | 416de85d8841dac883faa6f5339b2fb461a09e82 | |
| ToppCell | Entopeduncular-Neuronal|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.23e-06 | 192 | 137 | 7 | 4c35e5c28a40b439044797ba1f06cb7c36b2a8de | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / Treatment groups by lineage, cell group, cell type | 2.64e-06 | 197 | 137 | 7 | 1a1bee8da6e04b65935c40373eaee4d6c046d9a1 | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_AW_CX3CR1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.82e-06 | 199 | 137 | 7 | 744b63fba33b176ab7dde11646ccb313665505f7 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Classical_Dendritic_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.60e-06 | 148 | 137 | 6 | 12fa2c4922f03803006c606b1b16e79441e3bb13 | |
| ToppCell | P15-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.31e-05 | 167 | 137 | 6 | 5c3d0763f73628c71c71f9883556bb4f1639f3cc | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.31e-05 | 167 | 137 | 6 | 942134bbabe9972fae80cbc4ed4e94da52f55dc3 | |
| ToppCell | E12.5-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.55e-05 | 172 | 137 | 6 | ba99688e9f46671deccf824b1e77c6db0742d7df | |
| ToppCell | E12.5-Endothelial-proliferative_endothelial_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.55e-05 | 172 | 137 | 6 | 2136170f6e1204734cec7dbf7b32e7d5179b92b5 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.55e-05 | 172 | 137 | 6 | f6b4754a7e4b3e38030316a0ae00d932bfa87e41 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-Mes-Like|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.68e-05 | 103 | 137 | 5 | c11bb0238e81a42dad5d7687c9d22474129d803d | |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-05 | 176 | 137 | 6 | 74f851a398c7562dd713bc0d8d488c0037243112 | |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-05 | 176 | 137 | 6 | 31b5459a978d5cdde0af03a77401e0464d8c95ba | |
| ToppCell | droplet-Spleen-nan-24m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-05 | 179 | 137 | 6 | d50d29f26d5a2cd8c4cd4e1244e1bb8de072d159 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.01e-05 | 180 | 137 | 6 | df60970520fba2ac0639faa54096766d07418ca4 | |
| ToppCell | 18-Airway-Immune-Hematopoietic,_B_Cells|Airway / Age, Tissue, Lineage and Cell class | 2.01e-05 | 180 | 137 | 6 | 200cecbd8c12a4ec334583fdd5057397504de71e | |
| ToppCell | wk_20-22-Hematologic-Myeloid-pDC|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.07e-05 | 181 | 137 | 6 | 60607c5ff6d5b1cb416adc034491dca31c41e988 | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.07e-05 | 181 | 137 | 6 | 782716b8b1d447d2bbe09a693fa5ed7ebeac0efb | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.07e-05 | 181 | 137 | 6 | e2481291c236105774c53883e6f20da11941df9b | |
| ToppCell | 18-Distal-Immune-Hematopoietic,_B_Cells|Distal / Age, Tissue, Lineage and Cell class | 2.14e-05 | 182 | 137 | 6 | cd0b9f0a25147ec3bc1e32d698511d1c3b33891f | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.14e-05 | 182 | 137 | 6 | 33afbb7c4352b03266501b1f4f0e751c12c7350d | |
| ToppCell | IPF-Myeloid-DC_Langerhans|IPF / Disease state, Lineage and Cell class | 2.34e-05 | 185 | 137 | 6 | f8ee3cb2aa9ec70f9ce8797be2b155da27ef6464 | |
| ToppCell | droplet-Marrow-nan-21m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.34e-05 | 185 | 137 | 6 | 65dcb0a7ee64990a34a87c167b44497107f035ee | |
| ToppCell | P28-Endothelial-capillary_endothelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.42e-05 | 186 | 137 | 6 | 26a625ca0300055d6af3472aa0bfba59b73db292 | |
| ToppCell | Substantia_nigra-Neuronal|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.42e-05 | 186 | 137 | 6 | 3f889083fcffe516388e9b03a5e23af2010ced33 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Endothelial_Myeloid-Micro-Microglia-Micro_L1-6_C1QC|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.49e-05 | 187 | 137 | 6 | 17a37fc3a1d62fef3137e5ff26a84c0b8c80e124 | |
| ToppCell | E12.5-Endothelial|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.49e-05 | 187 | 137 | 6 | b8ed57b3c39ffbf750cd08a3e03ec11dae43d00e | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Endothelial_Myeloid-Micro|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.49e-05 | 187 | 137 | 6 | 1b0eb29394040555516677b9de75c15e769c4c53 | |
| ToppCell | normal_Lung-Myeloid_cells-pDCs|normal_Lung / Location, Cell class and cell subclass | 2.49e-05 | 187 | 137 | 6 | d36751372fd40a46441f07735c9c3c5dcb503f24 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Endothelial_Myeloid-Micro-Microglia|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.49e-05 | 187 | 137 | 6 | 11c773cf3dc1e725b7e4d8edd676c8a94a231d2a | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_dendritic-im_migrating_dendritic_(5)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.57e-05 | 188 | 137 | 6 | 8fc15c8b78fdd1a578e34325011bc5a87a8aab31 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_B-Memory_B_cells|GI_small-bowel / Manually curated celltypes from each tissue | 2.57e-05 | 188 | 137 | 6 | ab1384e6f71053946368502282aeebf1ba92d33e | |
| ToppCell | Substantia_nigra-Endothelial|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.64e-05 | 189 | 137 | 6 | bef8234bd9c4d6e3cdef0791d8066b39ba56ebba | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.64e-05 | 189 | 137 | 6 | 7659c7bbd58ee959a159294fb8d17317bbcc5681 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.72e-05 | 190 | 137 | 6 | 1c5cf933ce71fed5638b9ef31eb81f6c2b6dadbc | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.80e-05 | 191 | 137 | 6 | 63aa671837b79d2feb7ed1e67712cc01caf72bef | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.97e-05 | 193 | 137 | 6 | b38aaffbea36ef6c08ebe82675438f873c89b242 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.97e-05 | 193 | 137 | 6 | 2483bb7f398e4fa0ef09c8bd584ed25703853f03 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.97e-05 | 193 | 137 | 6 | bd08555f02db8bc903caacae57e80bb91e2556ce | |
| ToppCell | Thalamus-Neuronal|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.97e-05 | 193 | 137 | 6 | 712a4acd1167e43543950bc819ff11984e6f718d | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.97e-05 | 193 | 137 | 6 | 374d0526a071e973c3f43b4564f78f6933bb67ed | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.06e-05 | 194 | 137 | 6 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.06e-05 | 194 | 137 | 6 | f95c8dc242c9aebcadfe61b1ed033349cb7e5a88 | |
| ToppCell | Control-Myeloid-ncMonocyte|Control / Disease state, Lineage and Cell class | 3.15e-05 | 195 | 137 | 6 | fcb05948e7480dc53f06f3fc9b9c3fc129874edd | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.15e-05 | 195 | 137 | 6 | 562e4c0e4e81f6303e57b846da71d1667fc35963 | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_1|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.15e-05 | 195 | 137 | 6 | c9469e2d31beb30ebb64b3f0a5239e23119fbaa5 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.15e-05 | 195 | 137 | 6 | fa8ac154e5aebc26463ff84f0ad1038095770bc6 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.33e-05 | 197 | 137 | 6 | 1485933986921ff45669d9b7501c8d17050b3e97 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.33e-05 | 197 | 137 | 6 | dea1d29154c585ab588e50b83c7c8de7fe24d2d4 | |
| ToppCell | Frontal_cortex-Neuronal|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.53e-05 | 199 | 137 | 6 | f88039d862f3bfa01dc39d2de4f3f548dc5a0e61 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_VISp_Car3|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.93e-05 | 134 | 137 | 5 | 4ef5f395e321cf04e56560be2502a8aa157682f4 | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-nan|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.58e-05 | 137 | 137 | 5 | 587a369b148bb2600c06db39298feddfc99cb6ad | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.19e-05 | 147 | 137 | 5 | 9d7e965fe61bd7b31e09c4b2129a5a98c36f4811 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.19e-05 | 147 | 137 | 5 | 38552953ff65a0fc20bee6ef57dc5885306ad18b | |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Lgi2_(Golgi_interneuron)--|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 9.37e-05 | 77 | 137 | 4 | afe990041849a68fd75e0c11b633a7b90fefade1 | |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Lgi2_(Golgi_interneuron)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 9.37e-05 | 77 | 137 | 4 | ec8f625cae561986ed27dfaefa8f822dd1c4fba1 | |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Lgi2_(Golgi_interneuron)-|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 9.37e-05 | 77 | 137 | 4 | af7e1e76db33b115238b6fc61fc0dd86aab8e49d | |
| ToppCell | LPS_only-Myeloid-Dendritic_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.48e-05 | 148 | 137 | 5 | cb9365663f9cba35d47b5dd9079f42e88b70d915 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.11e-04 | 153 | 137 | 5 | 9b6675ace8a83c8d446b722301d0ec4e6840f3fc | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-04 | 157 | 137 | 5 | 2c5295043611bac7dfa4aef2146681bce4a33a8f | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.33e-04 | 159 | 137 | 5 | 0c2437da5443fc3aff66f8ef311f02aa434a1fb0 | |
| ToppCell | Control-Myeloid-Monocytes,_Macrophages-Mast-cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.33e-04 | 159 | 137 | 5 | 81782e9e370558d61af5e0c760ac9759d69fb725 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Mesenchymal|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 1.33e-04 | 159 | 137 | 5 | f34f2729a3872fbb2939e76ad35d7e25f71b8f57 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Mesenchymal-Unfolded_protein_responsible_cell|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 1.33e-04 | 159 | 137 | 5 | 929ed98f6c2ad14e8d5af5c6f11a5a3d4b388cf7 | |
| ToppCell | primary_visual_cortex-Non-neuronal-endothelial_cell-Endo-Endo_Ctla2a|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.41e-04 | 161 | 137 | 5 | a60ef3f390f56bb05b687b17986fe6382f69f260 | |
| ToppCell | primary_visual_cortex-Non-neuronal-endothelial_cell-Endo|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.45e-04 | 162 | 137 | 5 | 0bdb1e5ba33e162bec1acb28256c1405a7658ee5 | |
| ToppCell | primary_visual_cortex-Non-neuronal-endothelial_cell|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.45e-04 | 162 | 137 | 5 | 5799a602ef8d83925907e8e34532428be7330228 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-D-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.49e-04 | 163 | 137 | 5 | 8d2b2119c6b3d5b677da6f377fd85146590e1246 | |
| ToppCell | E12.5-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.49e-04 | 163 | 137 | 5 | c21114826bee1b05b411984326fef6b6e0d05316 | |
| ToppCell | E12.5-Endothelial-lymphatic_endothelial_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.49e-04 | 163 | 137 | 5 | 5d49414432db259a19df50d7944581d00b69f537 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-04 | 163 | 137 | 5 | 132aece9c79499b4bb3c2bde68d3d7202e1d8772 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-D|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.49e-04 | 163 | 137 | 5 | acfb2ece6202479e615d54fd3ecb8b4a571b5a18 | |
| ToppCell | frontal_cortex-Non-neuronal-endothelial_cell|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.53e-04 | 164 | 137 | 5 | 6a41a159134e605b80d5e731f9ed5bc803bb531b | |
| ToppCell | frontal_cortex-Non-neuronal-endothelial_cell-Endo|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.53e-04 | 164 | 137 | 5 | ec68954fc09b6850273b5e59caa6b09d02151097 | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-fibrocyte|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-04 | 165 | 137 | 5 | 8a52f2dbcbd2bc1662b5e3fac381463fdcc3bf14 | |
| ToppCell | wk_15-18-Epithelial-Airway_epithelial_progenitor-epi-prox-progenitor_intermediate_|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.58e-04 | 165 | 137 | 5 | f6887c64af0f26e33316bc5587487e24d76ece2a | |
| ToppCell | frontal_cortex-Non-neuronal-endothelial_cell-Endo-Endo_Ctla2a|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.62e-04 | 166 | 137 | 5 | 27af6c906cff1d40d134f0386db7708869691121 | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 1.72e-04 | 168 | 137 | 5 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Hematologic-leukocyte|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-04 | 168 | 137 | 5 | 5946204d42307391bc2160abe12850815f350aea | |
| ToppCell | 356C-Endothelial_cells-Endothelial-E|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.76e-04 | 169 | 137 | 5 | 0425d2580ed325178f522c0093ff4623de6ce7a8 | |
| ToppCell | droplet-Spleen-nan-21m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-04 | 169 | 137 | 5 | 7962165cab84af73d20b56eb70b1ed87c94025ef | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-Tuft-related-Tuft|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.76e-04 | 169 | 137 | 5 | 05e12524d68d409fed386ffad233305683b4575b | |
| ToppCell | 356C-Endothelial_cells-Endothelial-E-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.76e-04 | 169 | 137 | 5 | fec669968a77060bd77ee8695034e35a642c984f | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs-Plasmacytoid_DCs_L.1.5.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.81e-04 | 170 | 137 | 5 | b49f7c8a27078de2137ed04f74cfee30729cfa5e | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.81e-04 | 170 | 137 | 5 | 5d5f208682be21ed58320f5fc083a7898f8712da | |
| ToppCell | LPS-antiTNF-Myeloid-Dendritic_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.81e-04 | 170 | 137 | 5 | 3cbeea6bfa500928c413b1c6129f6dedc769cd1e | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-04 | 171 | 137 | 5 | 6a0fafb8fd9fc7671618eeb2bf528ce8ce86b794 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-goblet-Goblet_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.86e-04 | 171 | 137 | 5 | 48125d825ca2d7ef34564250f5b47d2a579e03c9 | |
| ToppCell | COVID_vent-Lymphocytic-Dendritic-pDC|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.86e-04 | 171 | 137 | 5 | 779c951d274ecbd1d546ac425d6c8e718623be5a | |
| ToppCell | COVID_vent-Lymphocytic-Dendritic|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.86e-04 | 171 | 137 | 5 | debbb071d260639b16269c94d172766908325c58 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-04 | 171 | 137 | 5 | e02b5831768dbb1b68998b672e55c9680ab0cc86 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.86e-04 | 171 | 137 | 5 | 55c7bf7211587fa08df13c0a4ff5b78a85d5439e | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-D_cells_(SST+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.86e-04 | 171 | 137 | 5 | fa5cc720bd0045d0307439be547b41d56def5b43 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.92e-04 | 172 | 137 | 5 | 6c17a1e586a72d1bd80c20c06370429c61dc9f85 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.92e-04 | 172 | 137 | 5 | 381ae1c3c07d0a424f43455ec571653b192a946a | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-04 | 172 | 137 | 5 | 30916a902c151907745756d14327e24adc34afef | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.92e-04 | 172 | 137 | 5 | 8a6a2b4c6654bc976e60a02d0e7303a9071ed55f | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.97e-04 | 173 | 137 | 5 | 20f7dfe7d92a3dbec9da9a1f3185aa10cb8f0a3c | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic-DN3_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-04 | 173 | 137 | 5 | 5d7c53c6d1cdd385e44b79b82faec901747d1736 | |
| Drug | AC1L1DSH | 7.13e-08 | 19 | 134 | 5 | CID000002487 | |
| Drug | NSC11411 | 1.99e-07 | 3 | 134 | 3 | CID000408117 | |
| Drug | Ro 64-6198 | 1.99e-07 | 3 | 134 | 3 | CID009844019 | |
| Drug | AC1L1I4J | 3.67e-07 | 11 | 134 | 4 | CID000004419 | |
| Drug | etonitazene | 7.87e-07 | 13 | 134 | 4 | CID000013493 | |
| Drug | metkephamid acetate | 1.98e-06 | 5 | 134 | 3 | CID005464183 | |
| Drug | R-84760 | 1.98e-06 | 5 | 134 | 3 | CID000133035 | |
| Drug | DALECK | 1.98e-06 | 5 | 134 | 3 | CID015942760 | |
| Drug | GPA 1657 | 1.98e-06 | 5 | 134 | 3 | CID000030503 | |
| Drug | RLH-033 | 1.98e-06 | 5 | 134 | 3 | CID000190867 | |
| Drug | Mr2097 | 1.98e-06 | 5 | 134 | 3 | CID005745592 | |
| Drug | AC1L2FKQ | 1.98e-06 | 5 | 134 | 3 | CID000020114 | |
| Drug | Tyr-tic-phe-phe-OH | 1.98e-06 | 5 | 134 | 3 | CID003035452 | |
| Drug | ICI 197067 | 1.98e-06 | 5 | 134 | 3 | CID003081077 | |
| Drug | mirfentanil | 1.98e-06 | 5 | 134 | 3 | CID000060697 | |
| Drug | BRL 52537 | 1.98e-06 | 5 | 134 | 3 | CID005244802 | |
| Drug | AC1L1TDW | 1.98e-06 | 5 | 134 | 3 | CID000060509 | |
| Drug | Etorphine | 3.94e-06 | 6 | 134 | 3 | DB01497 | |
| Drug | NIH10236 | 3.94e-06 | 6 | 134 | 3 | CID006439828 | |
| Drug | AC1L2OET | 3.94e-06 | 6 | 134 | 3 | CID000125331 | |
| Drug | AC1L3OP4 | 3.94e-06 | 6 | 134 | 3 | CID000092720 | |
| Drug | beta-methyl-2',6'-dimethyltyrosine | 3.94e-06 | 6 | 134 | 3 | CID000189865 | |
| Drug | NSC612111 | 3.94e-06 | 6 | 134 | 3 | CID000163346 | |
| Drug | AC1L1FBI | 3.94e-06 | 6 | 134 | 3 | CID000053641 | |
| Drug | KT-90 | 3.94e-06 | 6 | 134 | 3 | CID005492465 | |
| Drug | RX8008M | 3.94e-06 | 6 | 134 | 3 | CID000162443 | |
| Drug | AC1L2TFU | 3.94e-06 | 6 | 134 | 3 | CID000128241 | |
| Drug | DuP 747 | 3.94e-06 | 6 | 134 | 3 | CID000132447 | |
| Drug | 6-monoacetylmorphine | 6.35e-06 | 21 | 134 | 4 | CID000520352 | |
| Drug | Tyr-ala-phe-gly | 6.86e-06 | 7 | 134 | 3 | CID005487532 | |
| Drug | GR89696 | 6.86e-06 | 7 | 134 | 3 | CID000003505 | |
| Drug | EET-HO | 6.86e-06 | 7 | 134 | 3 | CID000135928 | |
| Drug | MET-CAMO | 6.86e-06 | 7 | 134 | 3 | CID006450159 | |
| Drug | phenylmorphan | 6.86e-06 | 7 | 134 | 3 | CID000146306 | |
| Drug | AC1Q6ZKG | 6.86e-06 | 7 | 134 | 3 | CID000031785 | |
| Drug | AC1L9PCU | 6.86e-06 | 7 | 134 | 3 | CID000451042 | |
| Drug | N-cyclopropylmethylnorazidomorphine | 6.86e-06 | 7 | 134 | 3 | CID005489191 | |
| Drug | 2-mercaptoacetate | 6.86e-06 | 7 | 134 | 3 | ctd:C017487 | |
| Drug | AC1L2YDY | 6.86e-06 | 7 | 134 | 3 | CID000130992 | |
| Drug | beta-naltrexamine | 6.86e-06 | 7 | 134 | 3 | CID005486948 | |
| Drug | ICI-199,441 | 6.86e-06 | 7 | 134 | 3 | CID003082717 | |
| Drug | NDTMB | 6.86e-06 | 7 | 134 | 3 | CID000134748 | |
| Drug | AC1L1I4V | 7.73e-06 | 22 | 134 | 4 | CID000004423 | |
| Drug | AC1Q1ZY1 | 1.09e-05 | 8 | 134 | 3 | CID000065964 | |
| Drug | ICI 204448 | 1.09e-05 | 8 | 134 | 3 | CID000003683 | |
| Drug | phenazocine | 1.09e-05 | 8 | 134 | 3 | CID000014706 | |
| Drug | metazocine | 1.09e-05 | 8 | 134 | 3 | CID000062518 | |
| Drug | AC1L1B1Q | 1.09e-05 | 8 | 134 | 3 | CID000001246 | |
| Drug | DIPPA | 1.09e-05 | 8 | 134 | 3 | CID000127914 | |
| Drug | dioxadrol | 1.09e-05 | 8 | 134 | 3 | CID000066269 | |
| Drug | Tyr-D-Ala-Gly-Phe-Leu-chloromethyl ketone | 1.09e-05 | 8 | 134 | 3 | CID005492572 | |
| Drug | AC1L2Y8M | 1.09e-05 | 8 | 134 | 3 | CID000130908 | |
| Drug | 14-methoxymetopon | 1.09e-05 | 8 | 134 | 3 | CID005486940 | |
| Drug | KT-89 | 1.09e-05 | 8 | 134 | 3 | CID005748450 | |
| Drug | binaltorphimine | 1.09e-05 | 8 | 134 | 3 | CID005484197 | |
| Drug | N-methyl nalorphine | 1.09e-05 | 8 | 134 | 3 | CID005748235 | |
| Drug | AC1LBBLW | 1.09e-05 | 8 | 134 | 3 | CID000579851 | |
| Drug | Oxymorphone hydrazone | 1.09e-05 | 8 | 134 | 3 | CID009577748 | |
| Drug | B-Ni | 1.32e-05 | 25 | 134 | 4 | CID000446236 | |
| Drug | AC1Q5SQW | 1.32e-05 | 25 | 134 | 4 | CID000003912 | |
| Drug | Dalamide | 1.55e-05 | 26 | 134 | 4 | CID000100169 | |
| Drug | Dam K | 1.63e-05 | 9 | 134 | 3 | CID005487344 | |
| Drug | AC1Q7A0V | 1.63e-05 | 9 | 134 | 3 | CID000001250 | |
| Drug | meptazinol | 1.63e-05 | 9 | 134 | 3 | CID000041049 | |
| Drug | Syndyphalin | 1.63e-05 | 9 | 134 | 3 | CID000174117 | |
| Drug | AC1LD4H9 | 1.63e-05 | 9 | 134 | 3 | CID000611919 | |
| Drug | M 285 | 1.63e-05 | 9 | 134 | 3 | CID000020435 | |
| Drug | MRZ 2549 | 1.63e-05 | 9 | 134 | 3 | CID000134837 | |
| Drug | 6-benzal-3-(cyclopropylmethyl)-4a,9-dihydroxy-1,2,4,5,7a,13-hexahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one | 1.81e-05 | 27 | 134 | 4 | CID005149021 | |
| Drug | AC1L3X5D | 1.81e-05 | 27 | 134 | 4 | CID000123704 | |
| Drug | Tgg Tripeptide | 1.81e-05 | 27 | 134 | 4 | CID000123715 | |
| Drug | SKF 10,047 | 1.81e-05 | 27 | 134 | 4 | CID000001235 | |
| Drug | AC1LCF1O | 2.32e-05 | 10 | 134 | 3 | CID000627285 | |
| Drug | normetazocine | 2.32e-05 | 10 | 134 | 3 | CID000001208 | |
| Drug | me fit | 2.32e-05 | 10 | 134 | 3 | CID000127921 | |
| Drug | profadol | 2.32e-05 | 10 | 134 | 3 | CID000009882 | |
| Drug | Bd 737 | 2.32e-05 | 10 | 134 | 3 | CID000131252 | |
| Drug | Naloxone-6-hydrazone | 2.32e-05 | 10 | 134 | 3 | CID009576788 | |
| Drug | Drofenine hydrochloride [548-66-3]; Down 200; 11.4uM; HL60; HT_HG-U133A | 2.32e-05 | 198 | 134 | 8 | 2714_DN | |
| Drug | Tyr-gly-gly-phe | 2.79e-05 | 30 | 134 | 4 | CID006453937 | |
| Drug | PD117302 | 3.18e-05 | 11 | 134 | 3 | CID000122115 | |
| Drug | Trimu-5 | 3.18e-05 | 11 | 134 | 3 | CID005487273 | |
| Drug | Wy-16,225 | 3.18e-05 | 11 | 134 | 3 | CID000040841 | |
| Drug | lofexidine | 3.18e-05 | 11 | 134 | 3 | CID000030667 | |
| Drug | AC1MI02C | 3.18e-05 | 11 | 134 | 3 | CID003035838 | |
| Drug | O-desmethyltramadol | 3.18e-05 | 11 | 134 | 3 | CID000130829 | |
| Drug | AC1MICD4 | 3.18e-05 | 11 | 134 | 3 | CID003021990 | |
| Drug | AC1LCENG | 3.18e-05 | 11 | 134 | 3 | CID000626667 | |
| Drug | SNC80 | 3.19e-05 | 31 | 134 | 4 | CID000123924 | |
| Drug | dl-Bremazocine | 3.19e-05 | 31 | 134 | 4 | CID000001223 | |
| Drug | AC1L1I5D | 3.19e-05 | 31 | 134 | 4 | CID000004429 | |
| Drug | U-54494A | 3.44e-05 | 2 | 134 | 2 | CID000122015 | |
| Drug | erinacine E | 3.44e-05 | 2 | 134 | 2 | CID005317180 | |
| Drug | N-butyrylhomoserine lactone | 3.44e-05 | 2 | 134 | 2 | ctd:C092312 | |
| Drug | Dynorphin (1-11) | 3.44e-05 | 2 | 134 | 2 | CID003086114 | |
| Drug | (-)-EKC | 3.44e-05 | 2 | 134 | 2 | CID000042800 | |
| Drug | 2-aminooxazole | 3.44e-05 | 2 | 134 | 2 | CID000558521 | |
| Drug | MR-1353 | 3.44e-05 | 2 | 134 | 2 | CID000197198 | |
| Drug | trefentanil | 3.44e-05 | 2 | 134 | 2 | CID000060727 | |
| Drug | Tedam | 4.22e-05 | 12 | 134 | 3 | CID000124900 | |
| Disease | Niemann-Pick disease type C1 (implicated_via_orthology) | 1.90e-05 | 2 | 129 | 2 | DOID:0070113 (implicated_via_orthology) | |
| Disease | alcohol use disorder (implicated_via_orthology) | 2.50e-05 | 195 | 129 | 7 | DOID:1574 (implicated_via_orthology) | |
| Disease | bilirubin measurement | 2.59e-05 | 442 | 129 | 10 | EFO_0004570 | |
| Disease | Parkinson's disease (implicated_via_orthology) | 6.84e-05 | 157 | 129 | 6 | DOID:14330 (implicated_via_orthology) | |
| Disease | Niemann-Pick disease (implicated_via_orthology) | 1.13e-04 | 4 | 129 | 2 | DOID:14504 (implicated_via_orthology) | |
| Disease | coronary artery disease | NPC1 TTC41P DYNC2H1 PECAM1 HECTD4 SIPA1 NEK9 TGFB1 DOCK5 PPP2R3A GPR149 C1QTNF1 TNS1 UNC13A BICC1 | 2.34e-04 | 1194 | 129 | 15 | EFO_0001645 |
| Disease | pulse pressure measurement | NPC1 DYNC2H1 MYT1 PECAM1 PCDHA8 SIPA1 NEK9 OPRL1 TGFB1 FCSK NFE2L2 UGT2A1 ACCSL STEAP1B CNOT1 BICC1 | 3.87e-04 | 1392 | 129 | 16 | EFO_0005763 |
| Disease | Autism Spectrum Disorders | 5.37e-04 | 85 | 129 | 4 | C1510586 | |
| Disease | Hepatic Insufficiency | 6.69e-04 | 9 | 129 | 2 | C1306571 | |
| Disease | myocardial infarction | 9.03e-04 | 350 | 129 | 7 | EFO_0000612 | |
| Disease | childhood trauma measurement, smoking behaviour measurement | 1.01e-03 | 45 | 129 | 3 | EFO_0005671, EFO_0007979 | |
| Disease | pulmonary fibrosis (implicated_via_orthology) | 1.22e-03 | 12 | 129 | 2 | DOID:3770 (implicated_via_orthology) | |
| Disease | Epilepsy | 1.36e-03 | 109 | 129 | 4 | C0014544 | |
| Disease | coronary artery disease, factor VII measurement | 1.46e-03 | 111 | 129 | 4 | EFO_0001645, EFO_0004619 | |
| Disease | sickle cell anemia (is_marker_for) | 1.67e-03 | 14 | 129 | 2 | DOID:10923 (is_marker_for) | |
| Disease | Hepatomegaly | 1.72e-03 | 54 | 129 | 3 | C0019209 | |
| Disease | von Willebrand factor measurement, coronary artery disease | 1.82e-03 | 118 | 129 | 4 | EFO_0001645, EFO_0004629 | |
| Disease | metabolic syndrome | 1.90e-03 | 200 | 129 | 5 | EFO_0000195 | |
| Disease | Withdrawal Symptoms | 2.11e-03 | 58 | 129 | 3 | C0087169 | |
| Disease | Drug Withdrawal Symptoms | 2.11e-03 | 58 | 129 | 3 | C0086189 | |
| Disease | Substance Withdrawal Syndrome | 2.11e-03 | 58 | 129 | 3 | C0038587 | |
| Disease | fibrinogen measurement, factor VII measurement | 2.11e-03 | 58 | 129 | 3 | EFO_0004619, EFO_0004623 | |
| Disease | reticulocyte count | PLK2 TMC6 HECTD4 PLPPR3 GCDH SIPA1 SLC12A5 GREB1L DOCK5 P2RY2 DNAH17 TNS1 | 2.15e-03 | 1045 | 129 | 12 | EFO_0007986 |
| Disease | Schizoaffective disorder-bipolar type | 2.19e-03 | 16 | 129 | 2 | EFO_0009965 | |
| Disease | renal fibrosis (implicated_via_orthology) | 2.47e-03 | 17 | 129 | 2 | DOID:0050855 (implicated_via_orthology) | |
| Disease | serum IgE measurement | 2.80e-03 | 64 | 129 | 3 | EFO_0004579 | |
| Disease | bitter alcoholic beverage consumption measurement | 2.81e-03 | 133 | 129 | 4 | EFO_0010092 | |
| Disease | myocardial infarction (implicated_via_orthology) | 3.06e-03 | 66 | 129 | 3 | DOID:5844 (implicated_via_orthology) | |
| Disease | pulmonary non-tuberculous mycobacterial infection | 3.09e-03 | 19 | 129 | 2 | MONDO_0018469 | |
| Disease | Nonorganic psychosis | 3.47e-03 | 69 | 129 | 3 | C0349204 | |
| Disease | Left Ventricle Remodeling | 3.77e-03 | 21 | 129 | 2 | C0600520 | |
| Disease | Ventricular Remodeling | 3.77e-03 | 21 | 129 | 2 | C0600519 | |
| Disease | cardiovascular disease | 4.05e-03 | 457 | 129 | 7 | EFO_0000319 | |
| Disease | Acute Lung Injury | 4.14e-03 | 22 | 129 | 2 | C0242488 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YRFLYHTVAQMFCST | 281 | Q99952 | |
| VMSTLLANINAYYAH | 896 | Q9UPW8 | |
| YMLSVFDESITFHSI | 361 | Q4AC99 | |
| YFHSNGSEYIMALTT | 351 | Q6ZRH7 | |
| SAYEFYHALDSENMT | 276 | Q99814 | |
| MHVTSQSLLSIYSYG | 176 | Q9Y614 | |
| DCQYLMATFVHVYIT | 401 | Q92903 | |
| LSHYMSINDSFYTSH | 261 | Q8TD16 | |
| AYLYQHSSTTMLSGV | 96 | A6NCI8 | |
| MSVDYISFSAHTDYQ | 386 | Q9UKF6 | |
| HDTTSYSFYMQRIKH | 411 | Q32M84 | |
| YSFYMQRIKHTDLES | 416 | Q32M84 | |
| TILHYMGTSTFSEYT | 136 | P11766 | |
| QYSTMLYAQRASHIL | 206 | Q5FYB1 | |
| FSDYSFSVIAMSYLI | 1151 | Q86UK0 | |
| QFMDRTHYLLTFSSS | 6 | P0C7U1 | |
| LTYHSERTVTFTYVM | 146 | P47775 | |
| HSVSDYLRQSYGLSM | 136 | Q68CP9 | |
| IVSYFNHMSASILPY | 506 | Q8WYK0 | |
| EISNIFSNYFSAMYS | 6 | P78545 | |
| TTAQYYLDMNTFTFD | 71 | A0A1B0GTC6 | |
| QNKSTEHYLSSSNYM | 841 | Q9H694 | |
| EHYLSSSNYMDCISS | 846 | Q9H694 | |
| MSYLNKLETNYSFTH | 691 | Q49A88 | |
| DALMCTTFHDYYVAL | 141 | Q9NXK6 | |
| FLSHLAIVDMSYASS | 61 | Q8NGT7 | |
| SVLTYRLSSHDYFML | 166 | Q9Y5H6 | |
| YSYISLTAMAIQHSA | 16 | Q5VYV0 | |
| VHKSVMASCSEYFYN | 86 | Q9H511 | |
| ETMHTLLDYTYTSKA | 121 | Q8WZ60 | |
| ITLYQMASQSSASHY | 291 | Q8TC57 | |
| SVYSFLFLYLRMHQT | 111 | Q86YN1 | |
| IIAYYNHFMDNTTLL | 111 | Q8TD19 | |
| DKANSLVMYHSTTYQ | 1756 | Q38SD2 | |
| LMVSSSYYSIGHSQD | 81 | Q76N89 | |
| TYNFTHYDRIQSLLM | 601 | Q9NQG7 | |
| THYFIHRIMSSSSYN | 6786 | Q5CZC0 | |
| FNSMSALHEIYSYIT | 1846 | Q9UIW2 | |
| FSQAYFIHTLSVMES | 96 | Q9H340 | |
| LFYNISSMKSTESYF | 81 | P16284 | |
| TEVDNYHFYSSIPSM | 221 | Q16236 | |
| VPIHDTISSYFMNYN | 141 | Q9Y6X5 | |
| SSYLALATLQAYASM | 926 | Q9P2S2 | |
| YLSLATLQAYTSMHL | 881 | Q9Y4C0 | |
| LALTMNHVYSFSVFE | 686 | P55160 | |
| ENPHTSTMALVFYYV | 176 | Q9NZV8 | |
| LVEASVYAYTMFFST | 571 | Q9HCN3 | |
| SHLHTTMYYFLTNLS | 51 | Q8NGN5 | |
| FYTYMLRSSYHTAEQ | 261 | Q8NGX1 | |
| IVESYFMLNSTLYFS | 541 | Q8IVL5 | |
| TLYFSYTHMVCRTAL | 551 | Q8IVL5 | |
| TMSTVHLSSDGTYFY | 11 | Q9Y4D8 | |
| AAASAYNYAEQTMSH | 236 | Q9BQ04 | |
| LHHYTTSYFIQTMAY | 71 | Q9Y2T5 | |
| VSIMLTKYAAYNTFH | 1426 | Q9C091 | |
| MAATYRLVVSTVNHY | 1 | Q06190 | |
| YMFHLAVSDALYAAS | 71 | P41231 | |
| SYIAMHYHTTNDLVQ | 511 | O95800 | |
| MEAVIFSLYNYASSR | 986 | Q86VI3 | |
| SIDYYNMFTSIFTLT | 126 | P41143 | |
| HMYTFIKLLANTSYV | 1431 | Q9UMZ3 | |
| KMIYSYSSHSVSSIA | 851 | Q5T6X5 | |
| LKATLLVSYNFYTMH | 121 | Q86SP6 | |
| TRVGATYFMTYHTVL | 1031 | O15118 | |
| TYFMTYHTVLQTSAD | 1036 | O15118 | |
| ATYMFHLALSDTLYV | 71 | P51582 | |
| YASVMEYFPTTRFSH | 336 | Q96BZ4 | |
| NLYLLDSTSRFMAYH | 1066 | Q9UHC9 | |
| LYNLHDMFHYTSTTT | 631 | Q9NZ94 | |
| SSYTSDNDMIVSIFY | 276 | Q8NG75 | |
| LFYYVAVSLMSHQTL | 156 | Q9P2J9 | |
| YSYMTSSASEFLLSL | 326 | Q8N0W3 | |
| RYMTFLHVYSAISSS | 2871 | Q8NCM8 | |
| SLDTSFSVFKYMALY | 926 | Q9NQ11 | |
| EIKVYITFHSYSQML | 296 | P15088 | |
| MHSNHYYQTVIFDTE | 156 | Q9BXJ1 | |
| LQQMDDSHYSHYIST | 961 | Q9H7D0 | |
| SISFFMSYVHTTVNE | 2986 | Q9UFH2 | |
| METRAHYNSSNKSYT | 191 | Q92947 | |
| TYDVHFYASFALIML | 536 | Q9HCG7 | |
| SHYSEMLAFTLTAFL | 141 | Q96JJ3 | |
| LLVLHASFSYMDSYN | 386 | Q5T197 | |
| LYRQSAMSFNIYFHA | 1806 | Q5TH69 | |
| SQHILQHMDFLYYLS | 236 | Q9HCS2 | |
| LVSLHISQYYFMSSC | 211 | Q9BW60 | |
| MSVYQDYSLHHISQF | 201 | Q9H6B9 | |
| LLKFHSAYYSSNLMA | 241 | P14735 | |
| HHTTSYFIQTMAYAD | 61 | Q99679 | |
| MVSYTITLVFQHYHA | 231 | Q12770 | |
| MDSYTSYCNAVSDLH | 461 | Q8WUM9 | |
| DQYNTFSSLYFLTVM | 116 | P48145 | |
| DHPYVFSDMTSYFTL | 411 | Q9H2X9 | |
| SIDYYNMFTSIFTLT | 136 | P41145 | |
| VIAIDYYNMFTSTFT | 126 | P41146 | |
| MSSYSLEQSYLHQNA | 371 | Q12947 | |
| TTTDYHTLVANYMSG | 1266 | Q5JY77 | |
| YSLTYNTIAMHSGVD | 371 | P58004 | |
| YLDHNSFDYSNTVMR | 286 | Q9BXR5 | |
| PEMLASYQSYSSTFH | 301 | Q8N660 | |
| PEMLASYQSYSSTFH | 301 | A0A087WUL8 | |
| QMTDLYHYITSYVVH | 71 | Q00889 | |
| IESLSDSTIYMAFYT | 591 | Q9P2J5 | |
| DSTIYMAFYTVAHLL | 596 | Q9P2J5 | |
| ASYYKSLNLLVSHFM | 286 | Q8N5V2 | |
| THSLYTTYKDYELMF | 666 | Q9P2F8 | |
| TTYKDYELMFHVSTL | 671 | Q9P2F8 | |
| LTSFFLNYSHTMVAT | 21 | Q11201 | |
| YTTYQDHEIMFHVST | 396 | Q96FS4 | |
| KLHNASNSEMVLYSY | 251 | Q9H1N7 | |
| TYHMYNADSISAQSK | 166 | P0DJJ0 | |
| TYHMYNADSISAQSK | 166 | P0DMP2 | |
| FYGVSSQYESLEHMT | 326 | Q15562 | |
| VSVSYYHFDLMNNLQ | 136 | O43704 | |
| MEGSKLHYFTNSLYS | 191 | Q7Z7B1 | |
| FFAVLHAIYTLSYAM | 151 | Q6NZ63 | |
| TIQEYMHLALYCFAS | 1061 | O75153 | |
| THYFSCTMLYLFAEA | 2281 | A5YKK6 | |
| AAFAAVYVSMYFNST | 256 | Q7Z2D5 | |
| QHLDSQEIYTSFYTM | 251 | Q92738 | |
| LELAHMLYYRSTSNN | 336 | Q96AN5 | |
| LYSYLSYITAEMFHL | 316 | Q9UBY0 | |
| YMLHQFLQYHVLSDS | 516 | Q96DM3 | |
| SAFAAVYVSMYFNSV | 211 | Q6T4P5 | |
| LYKQYIMDTVFHDSS | 221 | Q9HAI6 | |
| MTHVASQFASSYVFY | 126 | Q9NWX6 | |
| QSTHSIYMFFNTSEL | 126 | P01137 | |
| TYHMYNADSISAQSK | 166 | O75044 | |
| AYMHYSNISASADQA | 126 | Q9HBL0 | |
| LLPSTHYTATMYATN | 1011 | Q92752 | |
| YSSAFASSTNAYMLI | 546 | Q96K76 | |
| SSYNHLYLFHLITMA | 1431 | Q8IWV7 | |
| CESSYIMSVIHYFIT | 376 | Q6P2S7 | |
| MSTLLANINAYYAHT | 821 | O14795 | |
| SYQMYHQSEALALAS | 871 | Q8NB14 | |
| LSYNLMDTYSHQALK | 556 | Q9UPP1 | |
| ITLVYSMAHSFGESY | 356 | Q7Z403 | |
| ISQVTVLKYFSHYME | 566 | Q9NYY3 | |
| FEYMSYLQRHSITHS | 96 | Q9P0T4 | |
| DDSVLHLTFYYLMNL | 356 | Q13769 | |
| VSVYYSHVLQMLFFS | 2111 | Q5T4S7 | |
| RNFISYHLQDYMFET | 211 | P0DTE4 | |
| LFSQYSSTLYDVAME | 86 | O75132 | |
| NFDAYVSTLTDMYSN | 1086 | Q01538 |